5-aminosalicylates in inflammatory bowel disease--the more the merrier?
- PMID: 8680898
- DOI: 10.1097/00042737-199511000-00001
5-aminosalicylates in inflammatory bowel disease--the more the merrier?
Comment on
-
Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group.Eur J Gastroenterol Hepatol. 1995 Nov;7(11):1025-30. doi: 10.1097/00042737-199511000-00003. Eur J Gastroenterol Hepatol. 1995. PMID: 8680900 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources